The medical device maker has raised fresh capital from backers including Crimson International Investment to support its global growth plans.
"We are delighted to secure further funding, as well as another strategic investor and partner to take our pioneering Parkinson’s monitoring device into new markets. NICE’s positive evaluation and recommendation, which supports NHS use of PDMonitor, was a big endorsement for our business and technology."
The funding round was led by Pale blue dot with participation from Nucleus Capital and Intercalation.
"The new EU Batteries Regulation is necessary to ensure the sustainability of an industry that is essential to transitioning our economy away from fossil fuels. We invested in Infyos because they have the perfect blend of innovation and expertise to guide battery players through this complicated landscape."
Molten Ventures led the Series A round to support product development and international expansion.
"We are seeing huge demand from manufacturers looking for solutions to help them transform their operations in the face of increasing pressures and a worsening skills gap."